During the past decade, Arcturus Healthcare , PLC, Troy Internal Medicine Research Division conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 1 clinical trials were completed. i.e. 7.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arcturus Healthcare , PLC, Troy Internal Medicine Research Division" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Pfizer" with 5 trials sponsored, "Amgen" with 1 trials sponsored, "CymaBay Therapeutics, Inc." with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arcturus Healthcare , PLC, Troy Internal Medicine Research Division" #1 collaborator was "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Arcturus Healthcare , PLC, Troy Internal Medicine Research Division" are "Obesity" (4 trials), "Overweight" (4 trials), "Type 2 Diabetes" (4 trials), "Cardiovascular Disease" (2 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Arcturus Healthcare , PLC, Troy Internal Medicine Research Division" in a lesser frequency.

Most popular intervention types in "Arcturus Healthcare , PLC, Troy Internal Medicine Research Division" are "Drug" (13 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Tirzepatide" (5 trials), "Insulin Efsitora Alfa" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "13vPnC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arcturus Healthcare , PLC, Troy Internal Medicine Research Division" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Arcturus Healthcare , PLC, Troy Internal Medicine Research Division". undefined are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".